Martino, M.; Naso, V.; Loteta, B.; Canale, F.A.; Pugliese, M.; Alati, C.; Musuraca, G.; Nappi, D.; Gaimari, A.; Nicolini, F.;
et al. Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon. Int. J. Mol. Sci. 2022, 23, 13332.
https://doi.org/10.3390/ijms232113332
AMA Style
Martino M, Naso V, Loteta B, Canale FA, Pugliese M, Alati C, Musuraca G, Nappi D, Gaimari A, Nicolini F,
et al. Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon. International Journal of Molecular Sciences. 2022; 23(21):13332.
https://doi.org/10.3390/ijms232113332
Chicago/Turabian Style
Martino, Massimo, Virginia Naso, Barbara Loteta, Filippo Antonio Canale, Marta Pugliese, Caterina Alati, Gerardo Musuraca, Davide Nappi, Anna Gaimari, Fabio Nicolini,
and et al. 2022. "Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon" International Journal of Molecular Sciences 23, no. 21: 13332.
https://doi.org/10.3390/ijms232113332
APA Style
Martino, M., Naso, V., Loteta, B., Canale, F. A., Pugliese, M., Alati, C., Musuraca, G., Nappi, D., Gaimari, A., Nicolini, F., Mazza, M., Bravaccini, S., Derudas, D., Martinelli, G., & Cerchione, C.
(2022). Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon. International Journal of Molecular Sciences, 23(21), 13332.
https://doi.org/10.3390/ijms232113332
